首页> 外文期刊>PLoS Genetics >RNAi–Based Functional Profiling of Loci from Blood Lipid Genome-Wide Association Studies Identifies Genes with Cholesterol-Regulatory Function
【24h】

RNAi–Based Functional Profiling of Loci from Blood Lipid Genome-Wide Association Studies Identifies Genes with Cholesterol-Regulatory Function

机译:基于RNAi的血脂基因组-全基因组关联基因座功能谱分析可鉴定具有胆固醇调节功能的基因

获取原文
       

摘要

Genome-wide association studies (GWAS) are powerful tools to unravel genomic loci associated with common traits and complex human disease. However, GWAS only rarely reveal information on the exact genetic elements and pathogenic events underlying an association. In order to extract functional information from genomic data, strategies for systematic follow-up studies on a phenotypic level are required. Here we address these limitations by applying RNA interference (RNAi) to analyze 133 candidate genes within 56 loci identified by GWAS as associated with blood lipid levels, coronary artery disease, and/or myocardial infarction for a function in regulating cholesterol levels in cells. Knockdown of a surprisingly high number (41%) of trait-associated genes affected low-density lipoprotein (LDL) internalization and/or cellular levels of free cholesterol. Our data further show that individual GWAS loci may contain more than one gene with cholesterol-regulatory functions. Using a set of secondary assays we demonstrate for a number of genes without previously known lipid-regulatory roles (e.g. CXCL12, FAM174A, PAFAH1B1, SEZ6L, TBL2, WDR12) that knockdown correlates with altered LDL–receptor levels and/or that overexpression as GFP–tagged fusion proteins inversely modifies cellular cholesterol levels. By providing strong evidence for disease-relevant functions of lipid trait-associated genes, our study demonstrates that quantitative, cell-based RNAi is a scalable strategy for a systematic, unbiased detection of functional effectors within GWAS loci. Author Summary Complex traits and diseases are assumed to result from interactions between multiple genes in relevant biological processes. Recent genome-wide association studies have uncovered many novel genomic loci where genes with functional significance are expected. However, functional validation of such genes has thus far remained confined to single gene approaches. Here, we use RNA interference and high-content screening microscopy to profile 133 genes at 56 loci associated with blood lipid traits, cardiovascular disease, and/or myocardial infarction for a function in regulating cellular free cholesterol levels and the efficiency of low-density lipoprotein uptake. Our results suggest that a high number of trait-associated genes have conserved cholesterol-regulatory functions in cells, with several GWAS loci harboring more than one gene of likely functional significance. For a number of genes without previously known lipid-regulatory functions, consequences upon siRNA knockdown positively correlated with cellular levels of LDL receptor, a major determinant of blood LDL levels. Moreover, GFP–tagged fusion proteins of several candidates shifted cellular cholesterol levels to inverse directions than knockdown, and subcellular localization of some candidates was sterol-dependent. Our study generates a valuable resource for prioritization of lipid-trait/CAD/MI-associated genes for future in-depth mechanistic analyses and introduces cell-based RNAi as a scalable and unbiased tool for functional follow-up of GWAS loci.
机译:全基因组关联研究(GWAS)是揭示与共同特征和复杂人类疾病相关的基因组基因座的强大工具。但是,GWAS仅很少揭示有关关联的确切遗传成分和致病事件的信息。为了从基因组数据中提取功能信息,需要在表型水平上进行系统的后续研究的策略。在这里,我们通过应用RNA干扰(RNAi)分析GWAS鉴定的56个基因座中的133个候选基因来解决这些局限,这些基因与血脂水平,冠状动脉疾病和/或心肌梗塞有关,具有调节细胞中胆固醇水平的功能。击倒数量惊人(41%)的性状相关基因会影响低密度脂蛋白(LDL)内在化和/或游离胆固醇的细胞水平。我们的数据进一步表明,单个GWAS基因座可能包含一个以上具有胆固醇调节功能的基因。使用一组辅助测定,我们证明了许多基因没有先前已知的脂质调节作用(例如,CXCL12,FAM174A,PAFAH1B1,SEZ6L,TBL2,WDR12),这些基因的敲低与LDL-受体水平的改变和/或GFP的过表达有关带有标记的融合蛋白会逆向改变细胞胆固醇水平。通过为脂质性状相关基因的疾病相关功能提供有力的证据,我们的研究表明,基于细胞的定量RNAi是可扩展的策略,用于系统,公正地检测GWAS基因座内的功能效应子。作者摘要复杂的性状和疾病被认为是相关生物过程中多个基因之间相互作用的结果。最近的全基因组关联研究发现了许多新颖的基因组位点,这些基因位点具有功能上的重要意义。然而,迄今为止,此类基因的功能验证仍局限于单基因方法。在这里,我们使用RNA干扰和高内涵筛选显微镜对与血脂性状,心血管疾病和/或心肌梗塞相关的56个基因座上的133个基因进行分析,以调节细胞游离胆固醇水平和低密度脂蛋白的功能摄取。我们的结果表明,大量与性状相关的基因在细胞中守恒了胆固醇调节功能,其中几个GWAS基因座含有一个以上可能具有功能意义的基因。对于许多没有先前已知的脂质调节功能的基因,对siRNA敲低的后果与细胞LDL受体水平呈正相关,LDL受体是血液LDL水平的主要决定因素。此外,几个候选物的带有GFP标签的融合蛋白将细胞胆固醇水平转移到比敲除相反的方向,并且某些候选物的亚细胞定位是固醇依赖性的。我们的研究为脂质特性/ CAD / MI相关基因的优先级排序提供了宝贵的资源,以用于将来的深入机理分析,并介绍了基于细胞的RNAi作为GWAS基因座功能随访的可扩展且无偏见的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号